机译:对HLA-A2个体对A型流感病毒的免疫优势CD8〜+ T细胞反应的系统鉴定
Department of Clinical Microbiology and Immunology, Third Military Medical University, Chongqing 400038, China,Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Victoria 3084, Australia;
Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Victoria 3084, Australia;
Department of Microbiology and Immunology, Melbourne University, Parkville, Victoria 3052, Australia;
Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Victoria 3084, Australia;
Department of Microbiology and Immunology, Melbourne University, Parkville, Victoria 3052, Australia;
Department of Clinical Microbiology and Immunology, Third Military Medical University, Chongqing 400038, China;
Department of Microbiology and Immunology, Melbourne University, Parkville, Victoria 3052, Australia;
Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Victoria 3084, Australia;
机译:甲型流感病毒的蛋白是免疫优势CD8(+)T细胞反应的主要目标
机译:鉴定牛痘和天花病毒中受普通MHC I类分子,HLA-A2或HLA-B7限制的牛痘CD8 + T细胞表位。
机译:HLA-A2和B35受限制的汉坦病毒核蛋白CD8 + T细胞表位特异性免疫反应与肾综合征出血热中的轻度疾病相关
机译:血清学反对疫苗接种疫苗诱导的古典和目前流感病毒菌株对意大利畜群的伪论和猪流感的疫苗诱导
机译:浆细胞样细胞和呼吸道树突状细胞控制着对致命剂量流感病毒感染的病毒特异性CD8 T细胞反应的强度。
机译:对HLA-A2个体对甲型流感病毒的免疫优势CD8 + T细胞反应的系统鉴定
机译:对HLA-A2个体对甲型流感病毒的免疫优势CD8 + T细胞反应的系统鉴定